Management of adult refractory convulsive status epilepticus in the intensive care unit;Prise en charge des états de mal épileptiques convulsifs réfractaires en réanimation

Revue Neurologique

Volumn 158, Issue 11, 2002, Pages 1059-1068

  Outin, H ^a   Liot, P ^a   De Jonghe, B ^a   Thomas, P ^b  

^a CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^b PASTEUR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; MIDAZOLAM; PROPOFOL;

ARTIFICIAL VENTILATION; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; GENERAL ANESTHESIA; HUMAN; INTENSIVE CARE UNIT; PROGNOSIS; REVIEW;

ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; HUMANS; INTENSIVE CARE UNITS; STATUS EPILEPTICUS;

EID: 0036880484     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. AMINOFF MJ, SIMON RP. (1980). Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med, 69: 657-666.
2. ASSAL F, COEYTAUX A, Jallon P. (2000). L'état de mal résistant aux antiépileptiques. Neurophysiol Clin, 30: 139-45.
3. BENBADIS SR, TATUM WO. (2000). Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology, 55: 1421-1423.
4. BLECK TP. (1993). Advances in the management of refractory status epilepticus. Crit Care Med, 21: 955-977.
5. BLECK TP. (1999). Management approaches to prolonged seizures and status epilepticus. Epilepsia, 40 (Suppl 1): 59-63.
6. BOGGS JG, MARMAROU A, AGNEW JP, et al. (1998). Hemodynamic monitoring prior to and at the time of death in status epilepticus. Epilepsy Res, 31: 199-209.
7. BOGGS JG, PAINTER JA, DELORENZO RJ. (1993). Analysis of electrocardiographic changes in status epilepticus. Epilepsy Res, 14: 87-94.
8. BORRIS DJ, BERTRAM EH, KAPUR J. (2000). Ketamine controls prolonged status epilepticus. Epilepsy Res, 42: 117-122.
9. BROWN AS, HORTON JM. (1967). Status epilepticus treated by intravenous infusions of thiopentone sodium. Br Med J, 1: 27-28.
10. BROWN LA, LEVIN GM. (1998). Role of propofol in refractory status epilepticus. Ann Pharmacother, 32: 1053-1059.
11. CELESIA GG, GRIGG MM, ROSS E. (1988). Generalized status myoclonicus in acute anoxic and toxic-metabolic encephalopathies. Arch Neurol, 45: 781-784.
12. CHATRIAN GE (1990). Coma, other stages of altered responsiveness, and brain death. In Daly DD, Pedley TA. (eds). Current practice of clinical electroencephalography, pp. 425-487. Raven Press. New York.
13. COEYTAUX A, JALLON P. (2000). Des difficultés de définir et classer l'état de mal épileptique. Neurophysiol Clin, 30: 133-138.
14. COEYTAUX A, JALLON P, GALOBARDES B, MORABIA A. (2000). Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). Neurology, 55: 693-697.
15. CONFERENCE DE CONSENSUS EN RÉANIMATION ET MÉDECINE D'URGENCE. (1995). Prise en charge de l'état de mal épileptique. Rean Urg, 4: 387-96.
16. CRAWFORD TO, MITCHELL WG, FISHMAN LS, SNODGRASS SR. (1988). Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology, 38: 1035-1040.
17. CREMER OL, MOONS KG, BOUMAN EA, KRUIJSWIJK JE, DE SMET AM, KALKMAN CJ. (2001). Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet, 357: 117-118.
18. DELANTY N, FRENCH JA, LABAR DR, PEDLEY TA, ROWAN AJ. (2001). Status epilepticus arising de novo in hospitalized patients: an analysis of 41 patients. Seizure, 10: 116-119.
19. DE LORENZO RJ, PELLOCK JM, TOWNE AR, BOGGS JG. (1995). Epidemiology of status epilepticus. J Clin Neurophysiol, 12: 316-325.
20. DE LORENZO RJ, WATERHOUSE EJ, TOWNE AR, et al. (1998). Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia, 39: 833-840.
21. EPILEPSY FOUNDATION OF AMERICA'S WORKING GROUP ON STATUS EPILEPTICUS. (1993). Treatment of convulsive status epilepticus. JAMA, 270:854-859.
22. FOUNTAIN NB, ADAMS RE. (1999). Midazolam treatment of acute and refractory status epilepticus. Clin Neuropharmacol, 22: 261-267.
23. GENTON P, MCMENAMIN J. (2000). Aggravation of seizures by antiepileptic drugs: what to do in clinical practice. Epilepsia, 39 (Suppl 3): 26-29.
24. GILBERT DL, GARTSIDE PS, GLAUSER TA. (1999). Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: a meta-analysis. J Child Neurol, 14: 602-609.
25. HANDFORTH A, TREIMAN DM. (1994). A new, non paharmacologic model of convulsive status epilepticus induced by electrical stimulation: behavioral/electroencephalographic observations and response to phenytoin and phenobarbital. Epilepsy Res, 19: 15-25.
26. HANNA JP, RAMUNDO ML. (1998). Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology, 50: 301-303.
27. HAUSER WA. (1990). Status epilepticus: epidemiologic considerations. Neurology, 40:9-13.
28. HOVINGA CA, CHICELLA MF, ROSE DF, EADES SK, DALTON JT, PHELPS SJ. (1999). Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus. Ann Pharmacother, 33: 579-584.
29. HOWELL SJ, OWEN L, CHADWICK DW. (1989). Pseudostatus epilepticus. Q J Med, 71: 507-519.
30. IGARTUA J, SILVER P, MAYTAL J, SAGY M. (1999). Midazolam coma for refractory status epilepticus in children. Crit Care Med, 27: 1982-1985.
31. JALLON P. (1997). Épilepsie et coeur. Rev Neurol, (Paris) 153: 173-184.
32. JOLLIET P, HILLION C, CHEVROLET JC. (1991). Le coma barbiturique dans le traitement de l'état de mal convulsif réfractaire de l'adulte. Utilité de l'électroencéphalogramme continu aux soins intensifs. Schweiz Med Wochenschr, 121: 903-909.
33. KOFKE WA, YOUNG RS, DAVIS P, et al. (1989). Isoflurane for refractory status epilepticus: a clinical series. Anesthesiology, 71: 653-659.
34. KRISHNAMURTHY KB, DRISLANE FW. (1996). Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia, 37: 863-867.
35. KRISNAMURTHY KB, DRISLANE FW. (1999). Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia, 40: 759-762.
36. KRUMHOLZ A, STERN BJ, WEISS HD. (1988). Outcome from coma after cardiopulmonary resuscitation: relation to seizures and myoclonus. Neurology, 38: 401-405.
37. KUMAR A, BLECK TP. (1992). Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med, 20: 483-488.
38. LABAR DR, ALI A, ROOT J. (1994). High-dose intravenous lorazepam for the treatment of refractory status epilepticus. Neurology, 44: 1400-1403.
39. LOTHMAN EW, BERTRAM EH, BEKENSTEIN JW, PERLIN JB. (1989). Self-sustaining limbic status epilepticus induced by « continuous » hippocampal stimulation: electrographic and behavioural characteristics. Epilepsy Res, 3: 107-119.
40. LOWENSTEIN DH, ALLDREDGE BK. (1993). Status epilepticus at an urban public hospital in the 1980s. Neurology, 43: 483-488.
41. LOWENSTEIN DH, ALLDREDGE BK. (1998). Status epilepticus. N Engl J Med, 338: 970-976.
42. LOWENSTEIN DH, AMINOFF MJ. (1992). Clinical and EEG features of status epilepticus in comatose patients. Neurology, 42: 100-104.
43. LOWENSTEIN DH, AMINOFF MJ, SIMON RP. (1988). Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients. Neurology, 38: 395-400.
44. NARITOKU DK, SINHA S. (2000). Prolongation of midazolam half-life after sustained infusion for status epilepticus. Neurology, 54: 1366-1368.
45. NOUAILHAT F, LEVY-ALCOVER MA, GOULON M. (1985). Traitement de l'état de mal épileptique de l'adulte. Analyse rétrospective de 192 cas traités en réanimation. Rev Electroencephalogr Neurophysiol Clin, 14: 287-292.
46. NOUAILHAT F, OUTIN HD, SIMON N, MERRER J. (1992). Status epilepticus and serial seizures. In Tinker J. (ed). Care of the critically ill patient, pp. 1003-1028. Springer-Verlag. Londres.
47. O'BRIEN TJ, CASCINO GD, SO EL, HANNA DR. (1998). Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin. Neurology, 51: 1034-1039.
48. OSORIO I, REED RC. (1989). Treatment of refractory generalized tonic-clonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin. Epilepsia, 30: 464-471.
49. OUTIN HD, DE JONGHE B, HAYON J, et al. (1995). Prise en charge des états de mal épileptiques de l'adulte en réanimation. Réan Urg, 4: 454-459.
50. PAKALNIS A, DRAKE ME, PHILLIPS B. (1991). Neuropsychiatric aspects of psychogenic status epilepticus. Neurology, 41: 1104-1106.
51. PARENT JM, LOWENSTEIN DH. (1994). Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology, 44: 1837-1840.
52. PAYNE TA, BLECK TP. (1997). Status epilepticus. Crit Care Clin, 13: 17-38.
53. RAGGUENEAU JL. (2001). Le diagnostic des états de mal épileptiques par le monitorage de I'EEG en neuroréanimation. Ann Fr Anesth Réanim, 20: 14-20.
54. SHORVON S. (1994). Status Epilepticus. Its clinical features and treatment in children and adults. Cambridge University Press. Cambridge.
55. SINGHI S, BANERJEE S, SINGHI P. (1998). Refractory status epilepticus in children: role of continuous diazepam infusion. J Child Neurol, 13: 23-26.
56. STECKER MM, KRAMER TH, RAPS EC, O'MEEGHAN R, DULANEY E, SKAAR DJ. (1998). Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia, 39: 18-26.
57. THOMAS P. (1997). États de mal convulsifs: indications de I'EEG d'urgence. Neurophysiol Clin, 23: 398-405.
58. THOMAS P. (1999). Les états d'absence de l'épilepsie. Rev Neurol, 155: 1023-1038.
59. TOWNE AR, WATERHOUSE EJ, BOGGS JG, GARNETT LK, BROWN AJ, SMITH JR, DE LORENZO RJ. (2000). Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology, 54: 340-345.
60. TOWNE AR, PELLOCK JM, KO D, DE LORENZO RJ. (1994). Determinants of mortality in status epilepticus. Epilepsia, 35: 27-34.
61. TREIMAN DM. (1993). Generalized convulsive status epilepticus in the adult. Epilepsia, 34: 2-11.
62. TREIMAN DM. (1995). Electroclinical features of status epilepticus. J Clin Neurophysiol, 12: 343-362.
63. TREIMAN DM. (2000). Effective treatment for status epilepticus. In: Schmidt D, Schachter SC, (eds). Epilepsy problem solving in clinical practice, pp. 253-265. Martin Dunitz. Londres.
64. TREIMAN DM, MEYERS PD, WALTON NY, et al. (1998). A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med, 339: 792-798.
65. TREIMAN DM, WALTON NY, KENDRICK C. (1990). A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res, 5: 49-60.
66. UBERALL MA, TROLLMANN R, WUNSIEDLER U, WENZEL D. (2000). Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology, 54: 2188-2189.
67. WALKER IA, SLOVIS CM. (1997). Lidocaine in the treatment of status epilepticus. Acad Emerg Med, 4: 918-922.
68. WALKER MC, HOWARD RS, SMITH SJ, MILLER DH, SHORVON SD, HIRSCH NP. (1996). Diagnosis and treatment of status epilepticus on a neurological intensive care unit. QJM, 89: 913-920.
69. WALKER MC, SMITH SJ, SHORVON SD. (1995). The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations. Anaesthesia, 50: 130-135.
70. YAFFE K, LOWENSTEIN DH. (1993). Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology, 43: 895-900.
71. YEOMAN P, HUTCHINSON A, BYRNE A, SMITH J, DURHAM S. (1989). Etomidate infusions for the control of refractory status epilepticus. Intensive Care Med, 15: 255-259.